Association of progranulin polymorphism rs5848 with neurodegenerative diseases: a meta-analysis
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Association of progranulin polymorphism rs5848 with neurodegenerative diseases: a meta-analysis
Authors
Keywords
<em class=EmphasisTypeItalic >Progranulin</em>, Polymorphism, Neurodegenerative disease, Meta-analysis
Journal
JOURNAL OF NEUROLOGY
Volume 262, Issue 4, Pages 814-822
Publisher
Springer Nature
Online
2015-01-12
DOI
10.1007/s00415-014-7630-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinicopathologic variability of the GRN A9D mutation, including amyotrophic lateral sclerosis
- (2013) A. Cannon et al. NEUROLOGY
- Association between GRN rs5848 Polymorphism and Parkinson′s Disease in Taiwanese Population
- (2013) Kuo-Hsuan Chang et al. PLoS One
- Progranulin Mutations as Risk Factors for Alzheimer Disease
- (2013) David C. Perry et al. JAMA Neurology
- Progranulin: An emerging target for FTLD therapies
- (2012) Jennifer Gass et al. BRAIN RESEARCH
- Towards Unveiling the Genetics of Neurodegenerative Diseases
- (2012) Christina Lill et al. SEMINARS IN NEUROLOGY
- Potential Mechanisms of Progranulin-deficient FTLD
- (2011) Michael Emmerson Ward et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- rs5848 Variant of Progranulin Gene Is a Risk of Alzheimer’s Disease in the Taiwanese Population
- (2011) Ming-Jen Lee et al. Neurodegenerative Diseases
- Common Variant inGRNIs a Genetic Risk Factor for Hippocampal Sclerosis in the Elderly
- (2010) Dennis W. Dickson et al. Neurodegenerative Diseases
- The granulin gene family: from cancer to dementia
- (2009) Andrew Bateman et al. BIOESSAYS
- Rethinking ALS: The FUS about TDP-43
- (2009) Clotilde Lagier-Tourenne et al. CELL
- GRN3′UTR+78 C>T is not associated with risk for Parkinson’s disease
- (2009) B. Jasinska-Myga et al. EUROPEAN JOURNAL OF NEUROLOGY
- Progranulin expression correlates with dense-core amyloid plaque burden in Alzheimer disease mouse models
- (2009) Sandra Pereson et al. JOURNAL OF PATHOLOGY
- No major progranulin genetic variability contribution to disease etiopathogenesis in an ALS Italian cohort
- (2009) Roberto Del Bo et al. NEUROBIOLOGY OF AGING
- No association of PGRN 3′UTR rs5848 in frontotemporal lobar degeneration
- (2009) Sara Rollinson et al. NEUROBIOLOGY OF AGING
- The heritability and genetics of frontotemporal lobar degeneration
- (2009) J. D. Rohrer et al. NEUROLOGY
- Variation at GRN 3′-UTR rs5848 Is Not Associated with a Risk of Frontotemporal Lobar Degeneration in Dutch Population
- (2009) Javier Simón-Sánchez et al. PLoS One
- An association study between granulin gene polymorphisms and Alzheimer's disease in Finnish population
- (2008) Jayashree Viswanathan et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
- Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia
- (2008) Rosa Rademakers et al. HUMAN MOLECULAR GENETICS
- Deletion of the progranulin gene in patients with frontotemporal lobar degeneration or Parkinson disease
- (2008) Anne Rovelet-Lecrux et al. NEUROBIOLOGY OF DISEASE
- Genetic variability in progranulin contributes to risk for clinically diagnosed Alzheimer disease
- (2008) N. Brouwers et al. NEUROLOGY
- Progranulin variability has no major role in Parkinson disease genetic etiology
- (2008) K. Nuytemans et al. NEUROLOGY
- Progranulin genetic variability contributes to amyotrophic lateral sclerosis
- (2008) K. Sleegers et al. NEUROLOGY
- Loss of progranulin function in frontotemporal lobar degeneration
- (2008) Marc Cruts et al. TRENDS IN GENETICS
- Genetic studies of GRN and IFT74 in amyotrophic lateral sclerosis
- (2007) Shangxi Xiao et al. NEUROBIOLOGY OF AGING
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started